Midazolam Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Midazolam Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 04/02/2020. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-2305-05
- Dosage Form
- Injection
- Presentation
- Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)
- Initial Posting
- 04/02/2020
- Revised Date
Reason
Other